Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
ABBOTT BIOTHERAPEUTICS CORP (FACT) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/23/2010 8-K Quarterly results
04/05/2010 8-K Form 8-K - Current report
03/10/2010 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Agreement and Plan of Merger, among Abbott Laboratories, Amber Acquisition Inc. and Facet Biotech Corporation",
"Third Amendment to Rights Agreement, by and between Facet Biotech Corporation and Mellon Investor Services, LLC, as rights agent",
"Scott Stoffel 936-9502 Abbott Investors: Larry Peepo 847-935-6722 Facet Media: Cindy Leggett-Flynn 333-3810 Facet Investors: Jean Suzuki 454-2648 Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech"
02/26/2010 8-K Quarterly results, Conference call transcript
Docs: "FACET BIOTECH REPORTS FOURTH QUARTER AND FULL YEAR 2009 FINANCIAL RESULTS",
"Transcript of Webcast conference call held on February 23, 2010 regarding the financial results of Facet Biotech Corporation for the fourth quarter and full year ended December 31, 2009"
02/09/2010 8-K Form 8-K - Current report
02/03/2010 8-K Termination of a Material Definitive Agreement
01/26/2010 8-K Entry into a Material Definitive Agreement
01/11/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "FACET BIOTECH ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE 2 STUDY OF ELOTUZUMAB IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA"
12/16/2009 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Stockholders Agreement, by and between Facet Biotech Corporation and The Baupost Group, L.L.C., SAK Corporation and Seth A. Klarman",
"FACET BIOTECH ENTERS AGREEMENT WITH THE BAUPOST GROUP TO ALLOW PURCHASE OF ADDITIONAL SHARES"
12/15/2009 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Stockholders Agreement, by and between Facet Biotech Corporation, and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., BVF Investments, L.L.C., Investment 10, L.L.C., BVF Partners L.P., BVF Inc. and Mark N. Lampert",
"FACET BIOTECH'S BOARD OF DIRECTORS REITERATES RECOMMENDATION THAT STOCKHOLDERS NOT TENDER AT $17.50 PER SHARE"
12/08/2009 8-K Form 8-K - Current report
12/07/2009 8-K Form 8-K - Current report
11/04/2009 8-K Form 8-K - Current report
11/03/2009 8-K Quarterly results
Docs: "FACET BIOTECH REPORTS THIRD QUARTER 2009 FINANCIAL RESULTS"
10/30/2009 8-K Entry into a Material Definitive Agreement
10/01/2009 8-K Entry into a Material Definitive Agreement
10/01/2009 8-K Other Events
09/21/2009 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "FACET BIOTECH ADVISES STOCKHOLDERS TO TAKE NO ACTION IN RESPONSE TO BIOGEN IDEC'S OFFER"
09/10/2009 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation of Facet Biotech Corporation"
09/09/2009 8-K Form 8-K - Current report
09/09/2009 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi...
Docs: "Certificate of Designation, Preferences and Rights of the Series A Preferred Stock",
"Rights Agreement, effective as of September 7, 2009, between the Company and Mellon Investor Services LLC, as Rights Agent (including as Exhibit A the form of Certificate of Designation, Preferences and Rights of the Series A Preferred Stock, as Exhibit B the form of Right Certificate and as Exhibit C the Summary of Terms of Rights Agreement)"
09/08/2009 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "FACET BIOTECH'S BOARD OF DIRECTORS REJECTS BIOGEN IDEC'S UNSOLICITED PROPOSAL AS INADEQUATE"
09/08/2009 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "FACET BIOTECH CONFIRMS RECEIPT OF BIOGEN IDEC LETTER"
08/31/2009 8-K Form 8-K - Current report
08/07/2009 8-K Quarterly results, Conference call transcript
Docs: "FACET BIOTECH REPORTS SECOND QUARTER 2009 FINANCIAL RESULTS",
"Transcript of webcast conference call held on August 4, 2009 regarding the financial results of Facet Biotech Corporation for the quarter ended June 30, 2009 and update on company activities",
"FACET BIOTECH ANNOUNCES DACLIZUMAB PROGRAM IN MULTIPLE SCLEROSIS TO ADVANCE"
05/11/2009 8-K Form 8-K -- Current report
05/06/2009 8-K Quarterly results
Docs: "FACET BIOTECH REPORTS FIRST QUARTER 2009 FINANCIAL RESULTS"
05/04/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "RODERICK WONG WITHDRAWS DIRECTOR NOMINATIONS"
05/01/2009 8-K Form 8-K -- Current report
04/07/2009 8-K Form 8-K -- Current report
04/06/2009 8-K Form 8-K -- Current report
03/31/2009 8-K Form 8-K -- Current report
03/26/2009 8-K Form 8-K -- Current report
03/18/2009 8-K Quarterly results, Conference call transcript
Docs: "FACET BIOTECHPROVIDES 2009 FINANCIAL GUIDANCE AND LOWERS CASH UTILIZATION ESTIMATE",
"Transcript of webcast conference call held on March 16, 2009 regarding the financial results of Facet Biotech Corporation for the fourth quarter and full year ended December 31, 2008"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy